Evidence map›Paper›PMID 26873856›Full record

SynthesisMolecular neurobiology2017

SORL1 Is Associated with the Risk of Late-Onset Alzheimer's Disease: a Replication Study and Meta-Analyses.

Cheng-Cheng Zhang, Hui-Fu Wang, Meng-Shan Tan, Yu Wan, Wei Zhang, Zhan-Jie Zheng, Ling-Li Kong, Zi-Xuan Wang, Lin Tan, Teng Jiang and 2 more

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Transethnic analysis identifies SORL1 variants and haplotypes protective against Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Protective Variants in Alzheimer's Disease.Current genetic medicine reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Cheng-Cheng ZhangDepartment of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Qingdao, People's Republic of China.
Hui-Fu WangDepartment of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, No. 5 Donghai Middle Road, Qingdao, Shandong Province, 266071, People's Republic of China.
Meng-Shan TanDepartment of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, No. 5 Donghai Middle Road, Qingdao, Shandong Province, 266071, People's Republic of China.
Yu WanDepartment of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, No. 5 Donghai Middle Road, Qingdao, Shandong Province, 266071, People's Republic of China.
Wei ZhangDepartment of Emergency, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, People's Republic of China.
Zhan-Jie ZhengDepartment of Geriatric, Qingdao Mental Health Center, Qingdao, 266034, China.
Ling-Li KongDepartment of Geriatric, Qingdao Mental Health Center, Qingdao, 266034, China.
Zi-Xuan WangDepartment of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, No. 5 Donghai Middle Road, Qingdao, Shandong Province, 266071, People's Republic of China.
Lin TanCollege of Medicine and Pharmaceutics, Ocean University of China, Qingdao, 266000, China.
Teng JiangDepartment of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
Lan TanDepartment of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Qingdao, People's Republic of China. dr.tanlan@163.com.
Jin-Tai YuDepartment of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, No. 5 Donghai Middle Road, Qingdao, Shandong Province, 266071, People's Republic of China. yu-jintai@163.com.
Qingdao Municipal Hospital · CNQingdao University · CNOcean University of China · CNQingdao Mental Health Center · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sorting-related receptor gene (SORL1) has been defined as an interesting candidate gene for Alzheimer's disease (AD). Recently, one novel variant, rs11218343, within SORL1 was reported to be related to late-onset Alzheimer's disease (LOAD) in Caucasians, Korean, and Japanese. The aim of this case-control study is to investigate whether SORL1 rs11218343 contributes to susceptibility for LOAD in Chinese. Furthermore, our data, along with previously studies, were pooled for determining the risk of the rs11218343 polymorphism on LOAD. The rs11218343 polymorphism was genotyped in the 2350 independent subjects from Northern Han Chinese population (including 992 cases and 1358 age- and gender-matched controls). Result of the case-control study showed the association between rs11218343 polymorphism and the risk of LOAD in a Northern Han Chinese population (recessive model: odds ratio (OR) = 0.641, 95 % confidence interval (CI) = 0.464-0.884, P = 0.007; additive model: OR = 0.873, 95 % CI = 0.765-0.996, P = 0.043). The results of meta-analysis in subgroups (Caucasian and Asian) and the whole showed that the minor allele (C allele) within rs11218343 played a protective effect on AD risk (OR (95 % CI), 0.77 (0.72-0.83), 0.85 (0.79-0.91), 0.81 (0.76-0.85), respectively). In conclusion, the C allele in SORL1 rs11218343 may be a protective factor for LOAD in both Caucasian and Han Chinese.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAsian PeopleCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansLDL-Receptor Related ProteinsMaleMembrane Transport ProteinsPolymorphism, Single NucleotideWhite PeopleLDL-Receptor Related ProteinsMembrane Transport ProteinsSORL1 protein, humanAlzheimer’s diseaseAssociation studyMeta-analysesPolymorphismSORL1

Identifiers

PMID26873856
OpenAlexW2270830321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.